PCN79 IMPACT of Adjuvant Trastuzumab Emtansine (T-DM1) on the Incidence of HER2-Positive Metastatic Breast Cancer and Its Associated Savings for the Spanish National Healthcare System
Abstract
Authors
M. Martín J. Albanell E. Moreno J. Costa-Samarra I. Arroyo R. Colomer